Pacira BioSciences (PCRX) Current Deferred Revenue (2010 - 2017)
Pacira BioSciences (PCRX) recorded Current Deferred Revenue of $102,000 in Q4 2017, down 82.9% from $595,000 a year earlier.
Powered by 
Analysis
Pacira BioSciences (PCRX) Current Deferred Revenue (2010 - 2017) Analysis & Trends
Starting with Q4 2010, Pacira BioSciences' Current Deferred Revenue history includes 26 quarters.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of -36.3% (FY2012 to FY2017).
- Across earlier years, Current Deferred Revenue came in at $595,000 in FY2016 (-58.3%), $1.43 million in FY2015 (unchanged), $1.43 million in FY2014 (+41.5%) and $1.01 million in FY2013 (+3.7%).
- The Q4 2017 figure is the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 46.7% in Q3 2014, against a decline of 86.6% in Q1 2013 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Pacira BioSciences | 997.55 Mn | 59.58 Mn | 148.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 102,000.00 |
| Mar 31, 2017 | 520,000.00 |
| Dec 31, 2016 | 595,000.00 |
| Sep 30, 2016 | 822,000.00 |
| Jun 30, 2016 | 1.05 Mn |
| Mar 31, 2016 | 1.28 Mn |
| Dec 31, 2015 | 1.43 Mn |
| Sep 30, 2015 | 1.43 Mn |
| Jun 30, 2015 | 1.43 Mn |
| Mar 31, 2015 | 1.43 Mn |
| Dec 31, 2014 | 1.43 Mn |
| Sep 30, 2014 | 1.43 Mn |
| Jun 30, 2014 | 1.43 Mn |
| Mar 31, 2014 | 1.01 Mn |
| Dec 31, 2013 | 1.01 Mn |
| Sep 30, 2013 | 972,000.00 |
| Jun 30, 2013 | 972,000.00 |
| Mar 31, 2013 | 972,000.00 |
| Dec 31, 2012 | 972,000.00 |
| Sep 30, 2012 | 1.17 Mn |
API Access
Pacira BioSciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();